Nintedanib ethanesulfonate crystal

The invention relates to a nintedanib ethanesulfonate crystal. Specifically, the invention relates to a type A crystal of nintedanib diethanesulfonate. The the X-ray powder diffraction spectrum of the nintedanib diethanesulfonate type A crystal provided by the invention is shown by a 2theta value to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHU XUEYAN, SUN JIUDE, ZHANG JIASONG, GUO MENG, HU MINGTONG, WANG HUBO
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHU XUEYAN
SUN JIUDE
ZHANG JIASONG
GUO MENG
HU MINGTONG
WANG HUBO
description The invention relates to a nintedanib ethanesulfonate crystal. Specifically, the invention relates to a type A crystal of nintedanib diethanesulfonate. The the X-ray powder diffraction spectrum of the nintedanib diethanesulfonate type A crystal provided by the invention is shown by a 2theta value to have diffraction peaks at about 14.64, 18.79, 19.31, 20.11, 21.20, 22.45 and 26.71 degrees. The crystal provided by the invention has the characteristics of stable properties, difficult degradation, and no absorption of moisture, and is especially suitable for production of drugs. 本发明涉及尼达尼布乙磺酸盐结晶,具体而言,本发明涉及尼达尼布二乙磺酸盐的A型结晶。本发明的尼达尼布二乙磺酸盐A型结晶,其X-射线粉末衍射光谱用2θ值表示在约14.64、18.79、19.31、20.11、21.20、22.45、26.71°处有衍射峰。本发明的结晶性质稳定,不易降解、不吸潮,特别适合药物生产。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN106008308A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN106008308A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN106008308A3</originalsourceid><addsrcrecordid>eNrjZFDyy8wrSU1JzMtMUkgtyUjMSy0uzUnLz0ssSVVILqosLknM4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hgZmBgYWxgYWjsbEqAEA5l8mgQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Nintedanib ethanesulfonate crystal</title><source>esp@cenet</source><creator>ZHU XUEYAN ; SUN JIUDE ; ZHANG JIASONG ; GUO MENG ; HU MINGTONG ; WANG HUBO</creator><creatorcontrib>ZHU XUEYAN ; SUN JIUDE ; ZHANG JIASONG ; GUO MENG ; HU MINGTONG ; WANG HUBO</creatorcontrib><description>The invention relates to a nintedanib ethanesulfonate crystal. Specifically, the invention relates to a type A crystal of nintedanib diethanesulfonate. The the X-ray powder diffraction spectrum of the nintedanib diethanesulfonate type A crystal provided by the invention is shown by a 2theta value to have diffraction peaks at about 14.64, 18.79, 19.31, 20.11, 21.20, 22.45 and 26.71 degrees. The crystal provided by the invention has the characteristics of stable properties, difficult degradation, and no absorption of moisture, and is especially suitable for production of drugs. 本发明涉及尼达尼布乙磺酸盐结晶,具体而言,本发明涉及尼达尼布二乙磺酸盐的A型结晶。本发明的尼达尼布二乙磺酸盐A型结晶,其X-射线粉末衍射光谱用2θ值表示在约14.64、18.79、19.31、20.11、21.20、22.45、26.71°处有衍射峰。本发明的结晶性质稳定,不易降解、不吸潮,特别适合药物生产。</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20161012&amp;DB=EPODOC&amp;CC=CN&amp;NR=106008308A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20161012&amp;DB=EPODOC&amp;CC=CN&amp;NR=106008308A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHU XUEYAN</creatorcontrib><creatorcontrib>SUN JIUDE</creatorcontrib><creatorcontrib>ZHANG JIASONG</creatorcontrib><creatorcontrib>GUO MENG</creatorcontrib><creatorcontrib>HU MINGTONG</creatorcontrib><creatorcontrib>WANG HUBO</creatorcontrib><title>Nintedanib ethanesulfonate crystal</title><description>The invention relates to a nintedanib ethanesulfonate crystal. Specifically, the invention relates to a type A crystal of nintedanib diethanesulfonate. The the X-ray powder diffraction spectrum of the nintedanib diethanesulfonate type A crystal provided by the invention is shown by a 2theta value to have diffraction peaks at about 14.64, 18.79, 19.31, 20.11, 21.20, 22.45 and 26.71 degrees. The crystal provided by the invention has the characteristics of stable properties, difficult degradation, and no absorption of moisture, and is especially suitable for production of drugs. 本发明涉及尼达尼布乙磺酸盐结晶,具体而言,本发明涉及尼达尼布二乙磺酸盐的A型结晶。本发明的尼达尼布二乙磺酸盐A型结晶,其X-射线粉末衍射光谱用2θ值表示在约14.64、18.79、19.31、20.11、21.20、22.45、26.71°处有衍射峰。本发明的结晶性质稳定,不易降解、不吸潮,特别适合药物生产。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDyy8wrSU1JzMtMUkgtyUjMSy0uzUnLz0ssSVVILqosLknM4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hgZmBgYWxgYWjsbEqAEA5l8mgQ</recordid><startdate>20161012</startdate><enddate>20161012</enddate><creator>ZHU XUEYAN</creator><creator>SUN JIUDE</creator><creator>ZHANG JIASONG</creator><creator>GUO MENG</creator><creator>HU MINGTONG</creator><creator>WANG HUBO</creator><scope>EVB</scope></search><sort><creationdate>20161012</creationdate><title>Nintedanib ethanesulfonate crystal</title><author>ZHU XUEYAN ; SUN JIUDE ; ZHANG JIASONG ; GUO MENG ; HU MINGTONG ; WANG HUBO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN106008308A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHU XUEYAN</creatorcontrib><creatorcontrib>SUN JIUDE</creatorcontrib><creatorcontrib>ZHANG JIASONG</creatorcontrib><creatorcontrib>GUO MENG</creatorcontrib><creatorcontrib>HU MINGTONG</creatorcontrib><creatorcontrib>WANG HUBO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHU XUEYAN</au><au>SUN JIUDE</au><au>ZHANG JIASONG</au><au>GUO MENG</au><au>HU MINGTONG</au><au>WANG HUBO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Nintedanib ethanesulfonate crystal</title><date>2016-10-12</date><risdate>2016</risdate><abstract>The invention relates to a nintedanib ethanesulfonate crystal. Specifically, the invention relates to a type A crystal of nintedanib diethanesulfonate. The the X-ray powder diffraction spectrum of the nintedanib diethanesulfonate type A crystal provided by the invention is shown by a 2theta value to have diffraction peaks at about 14.64, 18.79, 19.31, 20.11, 21.20, 22.45 and 26.71 degrees. The crystal provided by the invention has the characteristics of stable properties, difficult degradation, and no absorption of moisture, and is especially suitable for production of drugs. 本发明涉及尼达尼布乙磺酸盐结晶,具体而言,本发明涉及尼达尼布二乙磺酸盐的A型结晶。本发明的尼达尼布二乙磺酸盐A型结晶,其X-射线粉末衍射光谱用2θ值表示在约14.64、18.79、19.31、20.11、21.20、22.45、26.71°处有衍射峰。本发明的结晶性质稳定,不易降解、不吸潮,特别适合药物生产。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN106008308A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Nintedanib ethanesulfonate crystal
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T00%3A51%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHU%20XUEYAN&rft.date=2016-10-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN106008308A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true